In the large WHI trial, estrogen plus progestogen was associated with a reduced rate of newly treated diabetes, and a large pooled analysis across many trials found roughly a 30 percent reduction in new-onset diabetes along with improvements in abdominal fat, insulin resistance, and cholesterol ratios.

Estrogen alone showed a smaller effect that did not reach statistical significance. Despite these encouraging numbers, no guideline endorses hormone therapy as a treatment to prevent diabetes - the trial authors themselves caution against using it for that purpose. The metabolic data are considered supportive of the therapy's overall picture, not a reason to prescribe it on their own.

What to know about this answer

There isn't much dispute about the direction of the metabolic data - it consistently favors hormone therapy. The disagreement, such as it is, is over whether that evidence should ever justify prescribing hormone therapy specifically for metabolic prevention rather than treating it as a welcome side effect.

What the research shows, and which source each finding rests on

WHI estrogen+progestogen: cumulative diabetes incidence 3.5% vs 4.2% on placebo, HR 0.79 (0.67-0.93), with an early fall in insulin resistance not explained by body size.

B[1]

WHI estrogen-alone: 8.3% vs 9.3%, HR 0.88 (0.77-1.01, p=0.072) - a smaller, non-significant reduction; the authors caution that estrogen should not be used with the intention of preventing diabetes.

B[2]

Pooled across 107 trials, hormone therapy reduced new-onset diabetes by about 30% (RR 0.7), reduced abdominal fat (-6.8%), insulin resistance measured by HOMA-IR (-12.9%), and the LDL/HDL cholesterol ratio (-15.7%); oral agents raised CRP and lowered protein S, while transdermal did not.

A[3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Supportive finding only, not an indication

the trial authors themselves and every current guideline

Even the strongest trial data here, from the WHI investigators themselves, explicitly caution against using hormone therapy with the intention of preventing diabetes; no guideline treats these metabolic findings as grounds for prescribing hormone therapy on their own.

B[2]

What would settle it: A trial designed with diabetes prevention as its primary endpoint in a population at elevated metabolic risk - none currently exists.

What is really going on here

  1. Am I being quoted a relative risk reduction (like '30 percent'), or the actual numbers and denominator behind it?

Questions for your doctor

  1. Do I have other diabetes risk factors where this metabolic data might be relevant to my overall plan?
  2. Is hormone therapy being suggested to me for symptoms and bone, or is diabetes prevention part of the reasoning, and should it be?
  3. What non-hormonal steps for insulin resistance and abdominal fat should I still prioritize?

Questions with no answer yet

If hormone therapy meaningfully lowers diabetes risk, why does no guideline endorse it as a diabetes-prevention treatment, and would a trial designed specifically around that endpoint change that?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The trial authors themselves explicitly caution against using hormone therapy with the intention of preventing diabetes, even though their own data showed a statistically significant reduction. No trial has been designed with diabetes prevention as its primary, prespecified endpoint in a population selected for elevated metabolic risk.

What would test it: A trial designed with diabetes prevention as its primary endpoint in a population at elevated metabolic risk, which does not currently exist.

Does the metabolic benefit, less abdominal fat, better insulin resistance, better cholesterol ratios, actually translate into fewer real diabetes diagnoses over the long term, or does it fade once treatment stops the way bone protection does?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The improvements in these metabolic markers were measured during active treatment. Whether they persist after stopping hormone therapy, the way bone protection is known to fade, has not been specifically tracked for these metabolic outcomes.

What would test it: A post-stopping follow-up study specifically tracking abdominal fat, insulin resistance, and diabetes incidence in women who discontinue hormone therapy after using it for metabolic reasons.

Sources

  1. 1.Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.Margolis KL, et al. Effect of oestrogen plus progestin on the incidence of diabetes (WHI). Diabetologia. 2004;47(7):1175-87. · Randomised trial
  2. 2.The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial.Bonds DE, et al. The effect of conjugated equine oestrogen on diabetes incidence (WHI estrogen-alone). Diabetologia. 2006;49(3):459-68. · Randomised trial
  3. 3.Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.Salpeter SR, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome. Diabetes Obes Metab. 2006;8(5):538-54. · Systematic review or guideline

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions